Tag: inclisiran
ACC 2017: Positive final results from ORION-1 phase II study of inclisiran
The Medicines Company and Alnylam Pharmaceuticals have announced positive final results from the ORI...
The Medicines Company announces positive 180-day results for PCSK9 inhibitor
The Medicines Company has announced positive top-line results from the interim analysis with 180-day...